|
G |
ACLY |
ATP citrate lyase |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of ACLY mRNA |
CTD |
PMID:26962056 |
|
NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased phosphorylation of AKT1 protein [Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased phosphorylation of AKT1 protein; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of BAX protein |
CTD |
PMID:31585129 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
ISO |
allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in decreased expression of BCL2 protein] |
CTD |
PMID:31585129 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CIDEC |
cell death inducing DFFA like effector c |
multiple interactions |
ISO |
[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of CIDEC mRNA; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of CIDEC mRNA] |
CTD |
PMID:31499194 |
|
NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of CPT1A mRNA |
CTD |
PMID:26962056 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
increases expression multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased expression of CYP2E1 mRNA; Ethylene Chlorohydrin results in increased expression of CYP2E1 protein allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 mRNA]; allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 mRNA]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 protein]; mithramycin A inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 mRNA]; mithramycin A inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 protein]; SCH772984 inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 mRNA]; SCH772984 inhibits the reaction [Ethylene Chlorohydrin results in increased expression of CYP2E1 protein] |
CTD |
PMID:31585129 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
FGF21 |
fibroblast growth factor 21 |
multiple interactions |
ISO |
[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of FGF21 mRNA; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of FGF21 mRNA] |
CTD |
PMID:31499194 |
|
NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions increases expression |
ISO |
allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC mRNA]; allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC mRNA]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC protein] Ethylene Chlorohydrin results in increased expression of GCLC mRNA; Ethylene Chlorohydrin results in increased expression of GCLC protein |
CTD |
PMID:31585129 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GLUL |
glutamate-ammonia ligase |
decreases expression multiple interactions |
ISO |
Ethylene Chlorohydrin results in decreased expression of GLUL mRNA Ethylene Chlorohydrin results in decreased expression of and results in decreased activity of GLUL protein |
CTD |
PMID:27596522 |
|
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased activity of GPT protein]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased activity of GPT protein]] |
CTD |
PMID:31499194 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of GSK3B mRNA |
CTD |
PMID:26962056 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased expression of HMOX1 mRNA; Ethylene Chlorohydrin results in increased expression of HMOX1 protein allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of HMOX1 mRNA]; allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of HMOX1 protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of HMOX1 mRNA]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of HMOX1 protein] |
CTD |
PMID:31585129 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased phosphorylation of MAPK1 protein allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased phosphorylation of MAPK1 protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31585129 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased phosphorylation of MAPK3 protein allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased phosphorylation of MAPK3 protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31585129 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
increases phosphorylation multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased phosphorylation of MTOR protein [Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased phosphorylation of MTOR protein; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased phosphorylation of MTOR protein] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO |
allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA]; allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 protein]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA]; Ascorbic Acid inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 protein] Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA; Ethylene Chlorohydrin results in increased expression of NFE2L2 protein |
CTD |
PMID:31585129 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] |
CTD |
PMID:26962056 PMID:31499194 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
PCK1 |
phosphoenolpyruvate carboxykinase 1 |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of PCK1 mRNA |
CTD |
PMID:26962056 |
|
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of PPARGC1A mRNA; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of PPARGC1A mRNA] |
CTD |
PMID:31499194 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 mRNA]; Sirolimus inhibits the reaction [Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE1 mRNA]] |
CTD |
PMID:31499194 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SERPINE2 |
serpin family E member 2 |
multiple interactions |
ISO |
Ethylene Chlorohydrin promotes the reaction [Lipopolysaccharides results in increased expression of SERPINE2 mRNA] |
CTD |
PMID:26962056 |
|
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
|
|
G |
SLC1A2 |
solute carrier family 1 member 2 |
decreases expression |
ISO |
Ethylene Chlorohydrin results in decreased expression of SLC1A2 protein |
CTD |
PMID:27596522 |
|
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
|
|
G |
SLC1A3 |
solute carrier family 1 member 3 |
decreases expression |
ISO |
Ethylene Chlorohydrin results in decreased expression of SLC1A3 mRNA; Ethylene Chlorohydrin results in decreased expression of SLC1A3 protein |
CTD |
PMID:27596522 |
|
NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
increases expression |
ISO |
Ethylene Chlorohydrin results in increased expression of SLC2A4 mRNA |
CTD |
PMID:26962056 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SP1 |
Sp1 transcription factor |
increases expression multiple interactions |
ISO |
Ethylene Chlorohydrin results in increased expression of SP1 mRNA Ethylene Chlorohydrin results in increased expression of and results in increased phosphorylation of SP1 protein; SCH772984 inhibits the reaction [Ethylene Chlorohydrin results in increased expression of and results in increased phosphorylation of SP1 protein]; SCH772984 inhibits the reaction [Ethylene Chlorohydrin results in increased expression of SP1 mRNA] |
CTD |
PMID:31585129 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in decreased phosphorylation of SRC protein; Sirolimus inhibits the reaction [[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in decreased phosphorylation of SRC protein] |
CTD |
PMID:31499194 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
[Ethylene Chlorohydrin co-treated with Lipopolysaccharides] results in increased expression of TNF mRNA |
CTD |
PMID:31499194 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Ethylene Chlorohydrin inhibits the reaction [Lipopolysaccharides results in increased expression of VEGFA mRNA] |
CTD |
PMID:26962056 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|